Major Challenges in Liver Pathology
Sunday, March 18, 2018, 8:30 AM – 12:00 PM
Location: Vancouver Convention Center – West Ballroom C
3 CME and 3 SAMs
Michael Torbenson, MD, Mayo Clinic, Rochester, MN
This year’s companion meeting focuses on difficult areas of surgical pathology of the liver. Six particularly important and challenging areas have been chosen. These topics will be addressed by speakers with both diagnostic and research expertise in these areas: (1) the best diagnostic approach to cystic biliary lesions, as classifying the lesions correctly has important clinical consequences; (2) how to approach IgG4 disease of the liver, which can mimic many other diseases; (3) Wilson’s disease and the challenges posed by the various clinical presentations and the variable histological findings; (4) an update on cholangiocarcinomas, with a focus on key diagnostic and terminology points; (5) soft tissue tumors of the liver–an always challenging area that you will be able to manage more comfortably after this talk; (6) and the pathologists’ role in diagnosing antibody mediated rejection of the liver–a critical role that brings into play clinical, laboratory, histological, and immunostain findings.
Upon completion of this educational activity, the learner will be able to:
- Integrate clinical information and laboratory testing into the interpretation of allograft liver biopsies for antibody mediated rejection.
- Understand the appropriate approach for liver biopsies in the setting of Wilson’s disease.
- Effectively use immunohistochemical stains when evaluating soft tissue tumors of the liver.
||Soft Tissue Tumors of the Liver: Hard Diagnoses Made Easy – Sometimes
Elizabeth Montgomery, MD, Johns Hopkins University, Baltimore, MD
||IgG4 Disease of the Liver: Challenging Mimicker of Other Diseases
Lizhi Zhang, MD, Mayo Clinic, Rochester, MN
||Wilson’s Disease: One Disease, Many Faces
Maha Guindi, FRCP, Cedars-Sinai Medical Center, Los Angeles, CA
||Cystic Biliary Lesions of the Liver: Not all Cysts are the Same
Susan Abraham, MD, MD Anderson Cancer Center, Houston, TX
||Cholangiocarcinoma: Update on Diagnosis and Terminology
Stephen Lagana, Columbia University, New York, NY
||Antibody Mediated Rejection in Liver Allografts: Key Role of Pathology Christopher Bellamy, Royal Infirmary of Edinburgh, Edinburgh, UK